Marketing Trumps Safety: the case of Antipsychotics
"The story’s pretty clear, and pretty embarrassing for the profession of psychiatry, which has allowed itself to be led by marketing," says Dr. Robert Rosenheck, Yale.
AstraZeneca Silenced Drug Study Creates Uproar_WashPost
Study 15 was pivotal to AstraZeneca gaining FDA approval to market Seroquel. The burial of negative data suggests that the approval process was tainted and the drug's license should be recalled.
ADHD Drugs Induce Hallucinations in Kids–FDA safety Officers
Three years have elapsed since FDA medical officers reported the findings of their comprehensive review of clinical trial data at an FDA pediatric advisory committee hearing (March, 2006).
Letter of Complaint to FDA Commissioner, 2007
Complaint about a surge of FDA administrative approvals for expanded use of highly toxic antipsychotic drugs for children. Approvals were determined by Dr. Thomas Laughren after secret deliberations–without disclosure of scientific data, without an advisory panel or open public discussion.
“Real Men, Real Depression” Marketing Masquerading as Medical News_Newsweek
The pharmaceutical industry’s latest antidepression drug marketing campaign is being launched with collaboration of the National Institute of Mental Health (NIMH) “Real Men, Real Depression campaign http://menanddepression.nimh.nih.gov/infopage.asp?ID=1
Real Men, Real Depression—-Marketing Masquerading as Medical News_Newsweek
The pharmaceutical industry’s latest antidepression drug marketing campaign is being launched with collaboration of the National Institute of Mental Health (NIMH)—
Lilly -Zyprexa Casualties-$1.2 Billion Settlements-More Casualties_NYT_WSJ
Eli Lilly's latest Zyprexa settlement will not affect civil or criminal investigations pending over Zyprexa from state attorneys general and federal prosecutors, which are continuing.
Company Documents Show Eli Lilly Promoted Zyprexa for Unapproved Use_NYT
The New York Times reports that internal marketing documents show that “Eli Lilly encouraged primary care physicians to use Zyprexa, in patients who did not have either condition.”
DRUG FILES SHOW LILLY PROMOTED ZYPREXA FOR UNAPPROVED USE
THE NEW YORK TIMES EXPOSE OF ELI LILLY SECRET ZYPREXA DOCUMENTS Part II.
Assaultive Prescribing of Psych Drugs for Children
Australian psychiatrist: "Does anyone else see tardive dysmentia after atypicalantipsychotics?"
U.S. Doctors are prescribing the antidepressant, Effexor (150mg) for infants under age one!
New Schizophrenia Drugs No Better Than CheaperGenerics_Bloomberg_WashPost
U.S. State Attorneys General should investigate the fraudulent marketing of the atypical neuroleptic drugs-and FDA's role in helping conceal the truth.
Psychiatrist Challenges Ethics of Yale Drug Experiment
The ethics of this radical drug experiment is being challenged by Dr. Jerald Block, a forthright psychiatrist and experienced system's analyst. His critical appraisal, published in the Bioethics Forum, Hastings Center Report.